$2.57 Billion is the total value of Tekla Capital Management LLC's 187 reported holdings in Q1 2018. The portfolio turnover from Q4 2017 to Q1 2018 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ABT | Abbott Laboratories | $47,853,000 | +5.0% | 798,619 | 0.0% | 1.86% | +5.9% | |
| CNC | Centene Corporation | $24,597,000 | +5.9% | 230,158 | 0.0% | 0.96% | +6.9% | |
| CVS | CVS Health Corporation | $22,801,000 | -14.2% | 366,521 | 0.0% | 0.89% | -13.5% | |
| OHI | Omega Healthcare Investors, Inc. | $15,677,000 | -1.8% | 579,785 | 0.0% | 0.61% | -1.0% | |
| AZN | AstraZeneca PLCsponsored adr | $15,478,000 | +0.8% | 442,600 | 0.0% | 0.60% | +1.7% | |
| SBRA | Sabra Health Care REIT, Inc. | $12,789,000 | -6.0% | 724,606 | 0.0% | 0.50% | -5.3% | |
| MPW | Medical Properties Trust, Inc. | $11,162,000 | -5.7% | 858,586 | 0.0% | 0.43% | -4.8% | |
| WELLPRI | Welltower Inc.6.50% preferred perpetual | $11,128,000 | -7.1% | 200,000 | 0.0% | 0.43% | -6.3% | |
| ACHC | Acadia Healthcare Company, Inc. | $10,673,000 | +20.1% | 272,400 | 0.0% | 0.42% | +21.0% | |
| SNH | Senior Housing Properties Trustshares | $10,125,000 | -18.2% | 646,554 | 0.0% | 0.39% | -17.6% | |
| Aegerion Pharmaceuticals, Inc.note 2.00% 8/15/19 | $10,010,000 | -3.1% | 13,000,000 | 0.0% | 0.39% | -2.5% | ||
| MRUS | Merus B.V. | $8,879,000 | -4.3% | 479,150 | 0.0% | 0.34% | -3.6% | |
| AVXS | AveXis, Inc. | $8,693,000 | +11.7% | 70,347 | 0.0% | 0.34% | +12.7% | |
| EXEL | Exelixis, Inc. | $8,612,000 | -27.1% | 388,822 | 0.0% | 0.34% | -26.5% | |
| AET | Aetna Inc. | $8,039,000 | -6.3% | 47,566 | 0.0% | 0.31% | -5.4% | |
| LTC | LTC Properties, Inc. | $7,968,000 | -12.7% | 209,673 | 0.0% | 0.31% | -11.9% | |
| RARE | Ultragenyx Pharmaceutical Inc. | $7,575,000 | +9.9% | 148,558 | 0.0% | 0.30% | +10.9% | |
| CTMX | CytomX Therapeutics, Inc. | $7,541,000 | +34.8% | 265,045 | 0.0% | 0.29% | +35.6% | |
| SNR | New Senior Investment Group Inc. | $7,230,000 | +8.2% | 883,919 | 0.0% | 0.28% | +8.9% | |
| SNY | Sanofisponsored adr | $7,210,000 | -6.8% | 179,900 | 0.0% | 0.28% | -6.0% | |
| GBT | Global Blood Therapeutics, Inc. | $6,276,000 | +22.7% | 129,948 | 0.0% | 0.24% | +23.9% | |
| VRNA | Verona Pharma plcsponsored adr | $5,500,000 | +67.8% | 275,000 | 0.0% | 0.21% | +69.8% | |
| ENDP | Endo International plcshares | $5,432,000 | -23.4% | 914,548 | 0.0% | 0.21% | -22.7% | |
| WMGI | Wright Medical Group N.V.ordinary shares | $5,293,000 | -10.6% | 266,781 | 0.0% | 0.21% | -9.6% | |
| FOMX | Foamix Pharmaceuticals Ltdshares | $4,773,000 | -14.6% | 930,398 | 0.0% | 0.19% | -13.9% | |
| VTR | Ventas, Inc. | $4,358,000 | -17.5% | 87,996 | 0.0% | 0.17% | -17.2% | |
| DOC | Physicians Realty Trust | $4,131,000 | -13.5% | 265,336 | 0.0% | 0.16% | -12.5% | |
| CLVS | Clovis Oncology, Inc. | $3,981,000 | -22.4% | 75,400 | 0.0% | 0.16% | -21.7% | |
| THC | Tenet Healthcare Corporation | $3,989,000 | +59.9% | 164,500 | 0.0% | 0.16% | +61.5% | |
| OVID | Ovid Therapeutics Inc. | $3,788,000 | -28.4% | 535,824 | 0.0% | 0.15% | -27.9% | |
| TSRO | TESARO, Inc. | $3,291,000 | -31.0% | 57,595 | 0.0% | 0.13% | -30.4% | |
| ARDX | Ardelyx, Inc. | $3,229,000 | -23.5% | 639,370 | 0.0% | 0.13% | -22.7% | |
| PRGO | Perrigo Company plcshares | $3,109,000 | -4.4% | 37,300 | 0.0% | 0.12% | -3.2% | |
| VRX | Valeant Pharmaceuticals International, Inc. | $3,057,000 | -23.4% | 192,000 | 0.0% | 0.12% | -22.7% | |
| SNDX | Syndax Pharmaceuticals, Inc. | $2,846,000 | +62.4% | 200,000 | 0.0% | 0.11% | +63.2% | |
| TTPH | Tetraphase Pharmaceuticals, Inc. | $2,638,000 | -51.3% | 859,322 | 0.0% | 0.10% | -50.7% | |
| Egalet Corporationnote 5.50% 4/1/20 | $2,586,000 | -22.4% | 7,000,000 | 0.0% | 0.10% | -21.7% | ||
| HZNP | Horizon Pharma plcshares | $2,313,000 | -2.7% | 162,900 | 0.0% | 0.09% | -2.2% | |
| ACHN | Achillion Pharmaceuticals, Inc. | $2,285,000 | +28.8% | 616,000 | 0.0% | 0.09% | +30.9% | |
| HSIC | Henry Schein, Inc. | $2,110,000 | -3.8% | 31,400 | 0.0% | 0.08% | -3.5% | |
| HR | Healthcare Realty Trust Incorporated | $1,884,000 | -13.7% | 68,000 | 0.0% | 0.07% | -13.1% | |
| ACIU | AC Immune SAshares | $1,777,000 | -19.2% | 171,813 | 0.0% | 0.07% | -18.8% | |
| EVH | Evolent Health, Inc.class a | $1,746,000 | +15.9% | 122,500 | 0.0% | 0.07% | +17.2% | |
| GKOS | Glaukos Corporation | $1,698,000 | +20.2% | 55,079 | 0.0% | 0.07% | +22.2% | |
| HTA | Healthcare Trust of America, Inc.class a | $1,217,000 | -11.9% | 46,000 | 0.0% | 0.05% | -11.3% | |
| NVAX | Novavax, Inc. | $1,199,000 | +69.4% | 571,000 | 0.0% | 0.05% | +74.1% | |
| WELL | Welltower Inc. | $1,165,000 | -14.7% | 21,400 | 0.0% | 0.04% | -15.1% | |
| HCP | HCP, Inc. | $1,057,000 | -11.0% | 45,500 | 0.0% | 0.04% | -10.9% | |
| MNKKQ | Mallinckrodt plcshares | $896,000 | -35.8% | 61,900 | 0.0% | 0.04% | -35.2% | |
| CYH | Community Health Systems, Inc. | $808,000 | -7.0% | 203,935 | 0.0% | 0.03% | -8.8% | |
| XNCR | Xencor, Inc. | $600,000 | +37.0% | 20,000 | 0.0% | 0.02% | +35.3% | |
| NSTG | NanoString Technologies, Inc. | $558,000 | +0.5% | 74,250 | 0.0% | 0.02% | +4.8% | |
| GMRE | Global Medical REIT Inc. | $510,000 | -15.3% | 73,400 | 0.0% | 0.02% | -13.0% | |
| RMR | The RMR Group Inc.class a | $520,000 | +17.9% | 7,441 | 0.0% | 0.02% | +17.6% | |
| ABIO | ARCA biopharma, Inc. | $405,000 | -63.7% | 811,227 | 0.0% | 0.02% | -62.8% | |
| CAH | Cardinal Health, Inc. | $395,000 | +2.3% | 6,300 | 0.0% | 0.02% | 0.0% | |
| BLCM | Bellicum Pharmaceuticals, Inc. | $394,000 | -22.0% | 60,000 | 0.0% | 0.02% | -21.1% | |
| ALQA | Alliqua BioMedical, Inc. | $318,000 | +5.3% | 165,000 | 0.0% | 0.01% | 0.0% | |
| CLDX | Celldex Therapeutics, Inc. | $247,000 | -17.7% | 105,800 | 0.0% | 0.01% | -16.7% | |
| QHCCQ | Quorum Health Corporation | $194,000 | +31.1% | 23,725 | 0.0% | 0.01% | +33.3% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-05-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Gilead Sciences, Inc. | 41 | Q2 2023 | 12.4% |
| Amgen, Inc. | 41 | Q2 2023 | 5.8% |
| Biogen Inc. | 41 | Q2 2023 | 6.5% |
| Vertex Pharmaceuticals Incorporated | 41 | Q2 2023 | 5.3% |
| Regeneron Pharmaceuticals, Inc. | 41 | Q2 2023 | 9.1% |
| Illumina, Inc. | 41 | Q2 2023 | 3.4% |
| BioMarin Pharmaceutical Inc. | 41 | Q2 2023 | 2.9% |
| Teva Pharmaceutical Industries Ltd. | 41 | Q2 2023 | 3.2% |
| Neurocrine Biosciences, Inc. | 41 | Q2 2023 | 1.4% |
| McKesson Corporation | 41 | Q2 2023 | 2.2% |
View Tekla Capital Management LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Rallybio Corp | January 23, 2023 | 1,727,067 | 4.6% |
| Zyla Life SciencesSold out | January 29, 2021 | 0 | 0.0% |
| ARCA biopharma, Inc. | January 24, 2020 | 36,068 | 2.3% |
| Verona Pharma plc | February 12, 2019 | 5,296,845 | 4.9% |
| Alliqua BioMedical, Inc. | February 12, 2018 | 165,000 | 3.3% |
| PIERIS PHARMACEUTICALS, INC. | February 12, 2018 | 1,962,380 | 4.4% |
| Intellipharmaceutics International Inc. | February 13, 2015 | 2,184,000 | 9.0% |
| HERON THERAPEUTICS, INC. /DE/ | February 14, 2014 | 20,598,613 | 4.2% |
| MEDWAVE INC | February 14, 2012 | 1,277,372 | 9.8% |
| MZT Holdings, Inc. | February 14, 2012 | 2,553,420 | 4.0% |
View Tekla Capital Management LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2023-08-10 |
| 13F-HR | 2023-05-10 |
| 13F-HR | 2023-02-10 |
| SC 13G/A | 2023-01-23 |
| 13F-HR | 2022-11-01 |
| 13F-HR | 2022-07-29 |
| 13F-HR | 2022-05-13 |
| 13F-HR | 2022-02-14 |
| SC 13G | 2022-01-21 |
| 13F-HR | 2021-11-12 |
View Tekla Capital Management LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.